secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biostax Corp. (—)
CIK:        0001559356
Form:       8-K
Filed at:   2023-09-13T23:59:59+00:00
Accession:  0001493152-23-032514
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Kelly Wilson and President Robert Wilson resign; Noreen Griffin appointed CEO
--------------------------------------------------------------------------------

- Robert Wilson resigned as President on July 25, 2023; no dispute cited.
- Kelly Wilson resigned as CEO on July 25, 2023; appointed President same day.
- Noreen Griffin named CEO under consulting agreement; monthly fee $20,834, deferred until $1M funding threshold with 8.5% interest.
- Griffin, age 70, previously VP of company and former CEO; family ties to both Wilson executives.
- Kelly Wilson's compensation continues under prior consulting agreement dated November 1, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1559356/000149315223032514/0001493152-23-032514-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1559356/000149315223032514/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-032514

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer